ReviewProbiotics and antimicrobial proteins2026
Efficacy of Probiotics and Postbiotics in Treating Dengue Fever - A Potential Strategy to Reduce Antibody-dependent Enhancement.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue virus (DENV), a member of the flavivirus family, is transmitted by the Aedes mosquito, with an incubation period of typically four to ten days, and causes a clinical spectrum of Dengue virus infection (DVI), ranging from classic dengue fever (DF) to sever illness, with symptoms such as vascular leakage, hemorrhage, organ dysfunction, and dysregulated inflammatory responses mediated by cytokines such as interleukin 6 (IL-6). However, Concerns about the absence of effective antiviral treatments or the efficacy and safety limitations of existing vaccines have led to considering novel treatment ways. Probiotics and postbiotics modulate mucosal and systemic immunity in a variety of ways, including mechanisms such as interaction with intestinal epithelial cells and dendritic cells (DCs), increased antigen (Ag) presentation, modulation of the toll-like receptor (TLR) signaling pathway, upregulation of regulatory pathways, and stimulation of antiviral cellular responses, including increased interferon-gamma (IFN-γ) production and cluster of differentiation 4
Indexed as
Identifiers
42201634What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.